{
    "clinical_study": {
        "@rank": "163039", 
        "arm_group": {
            "arm_group_label": "SGN-CD19A", 
            "arm_group_type": "Experimental", 
            "description": "SGN-CD19A (IV) once (Day 1) or twice (Days 1 and 8) every 21 days; dose range: 0.3-6 mg/kg"
        }, 
        "brief_summary": {
            "textblock": "This is a  phase 1, open-label, dose-escalation, multicenter study to evaluate the safety\n      and tolerability of SGN-CD19A in adult and pediatric patients with relapsed or refractory\n      B-lineage acute lymphoblastic leukemia (B-ALL), Burkitt lymphoma or leukemia, or B-lineage\n      lymphoblastic lymphoma (B-LBL)."
        }, 
        "brief_title": "A Safety Study of SGN-CD19A for Leukemia and Lymphoma", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Burkitt Lymphoma", 
            "Precursor B-cell Lymphoblastic Leukemia-Lymphoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Burkitt Lymphoma", 
                "Leukemia", 
                "Leukemia, Lymphoid", 
                "Precursor Cell Lymphoblastic Leukemia-Lymphoma", 
                "Precursor B-Cell Lymphoblastic Leukemia-Lymphoma", 
                "Lymphoma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients must be relapsed or refractory to at least 1 prior multi-agent\n             systemic therapy.  Pediatric patients must be relapsed or refractory to at least 2\n             prior multi-agent systemic therapies.  Patients with acute lymphoblastic leukemia who\n             are Philadelphia chromosome-positive must have failed a second generation tyrosine\n             kinase inhibitor.\n\n          -  Eastern Cooperative Oncology Group status of 2 or lower\n\n          -  Pathologically confirmed diagnosis of B-lineage acute lymphoblastic leukemia, Burkitt\n             leukemia or lymphoma, or B-lineage lymphoblastic lymphoma\n\n          -  Measurable disease\n\n        Exclusion Criteria:\n\n        -Allogeneic stem cell transplant  within 60 days, active acute or chronic\n        graft-versus-host disease (GvHD), or receiving immunosuppressive therapy as treatment for\n        GvHD"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "175", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01786096", 
            "org_study_id": "SGN19A-001"
        }, 
        "intervention": {
            "arm_group_label": "SGN-CD19A", 
            "description": "SGN-CD19A (IV) once (Day 1) or twice (Days 1 and 8) every 21 days; dose range:  0.3-6 mg/kg", 
            "intervention_name": "SGN-CD19A", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Burkitt Lymphoma", 
            "Antibodies, Monoclonal", 
            "Antibody-Drug Conjugate", 
            "B-Lineage Acute Lymphoblastic Leukemia", 
            "B-Lineage Lymphoblastic Lymphoma", 
            "Burkitt Leukemia", 
            "Monomethylauristatin F", 
            "Antigens, CD19", 
            "Drug Therapy"
        ], 
        "lastchanged_date": "May 30, 2014", 
        "location": [
            {
                "contact": {
                    "email": "sbiggers@uab.edu", 
                    "last_name": "Stephanie Biggers", 
                    "phone": "205-975-2944"
                }, 
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35294-3300"
                    }, 
                    "name": "University of Alabama at Birmingham"
                }, 
                "investigator": {
                    "last_name": "Uma Borate", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jadams@peds.uab.edu", 
                    "last_name": "Julia Adams", 
                    "phone": "205-638-2984"
                }, 
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35233"
                    }, 
                    "name": "University of Alabama at Birmingham / Children's Hospital of Alabama"
                }, 
                "investigator": {
                    "last_name": "Joseph Pressey, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mcclure.pamela@mayo.edu", 
                    "last_name": "Pamela McClure", 
                    "phone": "480-301-4963"
                }, 
                "facility": {
                    "address": {
                        "city": "Scottsdale", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85259"
                    }, 
                    "name": "Mayo Clinic Arizona"
                }, 
                "investigator": {
                    "last_name": "Raoul Tibes, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "brbrophy@coh.org", 
                    "last_name": "Brianna Brophy", 
                    "phone": "626-256-4673", 
                    "phone_ext": "89448"
                }, 
                "facility": {
                    "address": {
                        "city": "Duarte", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91010"
                    }, 
                    "name": "City of Hope"
                }, 
                "investigator": {
                    "last_name": "Robert Chen, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Mayo Clinic Clinical Trials ReferralOffice", 
                    "phone": "507-538-7623"
                }, 
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32224"
                    }, 
                    "name": "Mayo Clinic Cancer Center"
                }, 
                "investigator": {
                    "last_name": "James Foran, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Jennifer.Flanary@allkids.org", 
                    "last_name": "Jennifer Flanary", 
                    "phone": "727-767-6466"
                }, 
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33701"
                    }, 
                    "name": "All Children's Hospital"
                }, 
                "investigator": {
                    "last_name": "Gregory Hale, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "megan.borase@moffitt.org", 
                    "last_name": "Megan Borase", 
                    "phone": "813-745-2591"
                }, 
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33612"
                    }, 
                    "name": "H. Lee Moffitt Cancer Center & Research Institute"
                }, 
                "investigator": {
                    "last_name": "Bijal Shah, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Melissa.schink@choa.org", 
                    "last_name": "Melissa Schink", 
                    "phone": "404-785-1645"
                }, 
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30322"
                    }, 
                    "name": "Children's Healthcare of Atlanta / Emory University"
                }, 
                "investigator": {
                    "last_name": "Todd Cooper, D.O.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "MBURKE19@PARTNERS.ORG", 
                    "last_name": "Meghan Burke", 
                    "phone": "617-643-5126"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Massachusetts General Hospital"
                }, 
                "investigator": {
                    "last_name": "Amir Fathi, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "HilaryN_Hall@dfci.harvard.edu", 
                    "last_name": "Hilary Hall", 
                    "phone": "617-632-6829"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Boston Children's Hospital"
                }, 
                "investigator": {
                    "last_name": "Lewis Silverman, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Stacie-AnnS_Sammott@DFCI.HARVARD.EDU", 
                    "last_name": "Stacie-Ann Sammott", 
                    "phone": "617-632-6363"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Dana-Farber Cancer Institute"
                }, 
                "investigator": {
                    "last_name": "Daniel DeAngelo, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "willarde@mskcc.org", 
                    "last_name": "Emily Willard"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Memorial Sloan Kettering Cancer Center"
                }, 
                "investigator": {
                    "last_name": "Tanya Trippett, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Courtney.Blank@cchmc.org", 
                    "last_name": "Courtney Blank", 
                    "phone": "513-803-3255"
                }, 
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45229"
                    }, 
                    "name": "Cincinnati Children's Hospital Medical Center"
                }, 
                "investigator": {
                    "last_name": "Maureen O'Brien, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase 1, Open-Label, Dose-Escalation Study of SGN-CD19A in Patients With B-Lineage Acute Lymphoblastic Leukemia and Highly Aggressive Lymphomas", 
        "overall_contact": {
            "email": "clinicaltrials@seagen.com", 
            "last_name": "Terri Lowe", 
            "phone": "866-333-7436"
        }, 
        "overall_official": {
            "affiliation": "Seattle Genetics, Inc.", 
            "last_name": "Tina Albertson, MD, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Incidence of adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Through 1 month post last dose"
            }, 
            {
                "measure": "Incidence of laboratory abnormalities", 
                "safety_issue": "Yes", 
                "time_frame": "Through 1 month post last dose"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01786096"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Objective response according to modified response criteria for acute myeloid leukemia (Cheson 2003) or revised response criteria for malignant lymphoma (Cheson 2007)", 
                "safety_issue": "No", 
                "time_frame": "Through 1 month post last dose"
            }, 
            {
                "measure": "Duration of response", 
                "safety_issue": "No", 
                "time_frame": "Until disease progression or start of new anticancer treatment, an expected average of 3 months"
            }, 
            {
                "measure": "Overall survival", 
                "safety_issue": "No", 
                "time_frame": "Until death or study closure, an expected average of 6 months"
            }, 
            {
                "measure": "Blood concentrations of SGN-CD19A and metabolites", 
                "safety_issue": "No", 
                "time_frame": "Cycles 1, 2, and 4:  predose, 30 minutes, and up to 2, 4, 8, 24, 72, 120, 168, and 336 hours post dose start; All other cycles:  predose, 30 minutes, and 168 and 336 hours post dose start; and 1 month post last dose"
            }, 
            {
                "measure": "Incidence of antitherapeutic antibodies", 
                "safety_issue": "Yes", 
                "time_frame": "Predose in most cycles and 1 month post last dose"
            }
        ], 
        "source": "Seattle Genetics, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seattle Genetics, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}